These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31283604)

  • 1. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid on 68Ga DOTANOC PET-CT.
    Tripathy S; Aggrawal S; Subudhi K; Kumar R; Narwal A
    Clin Nucl Med; 2019 Sep; 44(9):e546-e547. PubMed ID: 31283604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases.
    Mahajan S; Shaha A; Grewal RK
    Clin Nucl Med; 2018 Feb; 43(2):136-138. PubMed ID: 29261627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Therapeutic Uptake of Intrathyroid Metastasis of Midgut Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE Imaging.
    Vija Racaru L; Sinigaglia M; Fontaine S; DʼAure D; Courbon F; Dierickx L
    Clin Nucl Med; 2019 Jul; 44(7):e445-e448. PubMed ID: 31021912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid carcinoma metastasizing to the submandibular gland: Sonographic findings.
    Golant BT; Velez-Perez A; Krishnamurthy S; Guo M; Mousavi S; Hu MI; Varghese JM; Zafereo ME; Debnam JM
    J Clin Ultrasound; 2020 May; 48(4):227-230. PubMed ID: 32045024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
    Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
    Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
    Golubić AT; Pasini Nemir E; Žuvić M; Mutvar A; Kusačić Kuna S; Despot M; Samardžić T; Huić D
    Nucl Med Commun; 2017 Jul; 38(7):636-641. PubMed ID: 28562377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
    Archier A; Heimburger C; Guerin C; Morange I; Palazzo FF; Henry JF; Schneegans O; Mundler O; Abdullah AE; Sebag F; Imperiale A; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1027-33. PubMed ID: 26497699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of
    Tuncel M; Kılıçkap S; Süslü N
    Ann Nucl Med; 2020 Sep; 34(9):663-674. PubMed ID: 32602032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma - PET/CT imaging with 68Ga-labelled gastrin and somatostatin analogues.
    Kunikowska J; Ziemnicka K; Pawlak D; Ruchała M; Kolasa A; Janicka-Jedyńska M; Woźniak A; Mikołajczak R; Królicki L
    Endokrynol Pol; 2016; 67(1):68-71. PubMed ID: 26884118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma.
    Rodríguez-Bel L; Sabaté-Llobera A; Rossi-Seoane S; Reynés-Llompart G; Vercher Conejero JL; Cos-Domingo M; Moreno-Llorente P; Pérez-Maraver M; Cortés-Romera M; Gámez Cenzano C
    Clin Nucl Med; 2019 Mar; 44(3):194-200. PubMed ID: 30562193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-DOTATOC PET/CT in Thyroid Metastases of Lung Carcinoid.
    Leccisotti L; Lorusso M; Giannetta E; Isidori AM; Rufini V
    Clin Nucl Med; 2018 Dec; 43(12):e492-e494. PubMed ID: 30358622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.
    Berzaczy D; Giraudo C; Haug AR; Raderer M; Senn D; Karanikas G; Weber M; Mayerhoefer ME
    Clin Nucl Med; 2017 Sep; 42(9):669-674. PubMed ID: 28682844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
    Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.
    Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
    Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-DOTATATE PET/CT in Nonneuroendocrine Tumors: A Pictorial Essay.
    Yamaga LYI; Wagner J; Funari MBG
    Clin Nucl Med; 2017 Jun; 42(6):e313-e316. PubMed ID: 28240663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG DOTANOC Mismatch in In Vivo Characterization and Grading of Neuroendocrine Tumor.
    Mukherjee A; Agarwal KK; Bal C; Kumar R
    Clin Nucl Med; 2016 Dec; 41(12):e511-e513. PubMed ID: 27749422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified?
    Sharma P; Arora S; Mukherjee A; Pal S; Sahni P; Garg P; Khadgawat R; Thulkar S; Bal C; Kumar R
    Clin Nucl Med; 2014 Jan; 39(1):37-43. PubMed ID: 24152621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ileal Neuroendocrine Tumor With Bilateral Breast and Ovarian Metastases: Findings on 68Ga-DOTANOC PET/CT Scan.
    Tripathy S; Naswa N; Jha P; Reddy S; Parida GK
    Clin Nucl Med; 2019 Sep; 44(9):e532-e534. PubMed ID: 31274557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT Revealing a Medullary Thyroid Carcinoma.
    Ciappuccini R; Edet-Sanson A; Saguet-Rysanek V; Gauthé M; Bardet S
    Clin Nucl Med; 2019 Aug; 44(8):663-665. PubMed ID: 31274618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.